Artiva-Biotherapeutics on Bioeconhttps://en.bioecon.ru/companies/artiva-biotherapeutics/Recent content in Artiva-Biotherapeutics on BioeconHugoen-USSat, 11 Jul 2026 14:19:14 +0700NK-cell & CAR-NK therapyhttps://en.bioecon.ru/technology/nk-cell-car-nk-therapy/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/nk-cell-car-nk-therapy/CAR-NK and NK-cell therapy — allogeneic, off-the-shelf effector cells with low toxicity (minimal CRS, no GVHD) against solid and haematological cancers; iPSC-NK is the scalable platform.